大肠癌筛查经济学评价研究进展

doi:10.11904/j.issn.1002-3070.2015.05.017

摘要/Abstract

摘要： 大肠癌已经成为威胁世界各国居民健康的主要癌症之一,需要大量的卫生资源对其进行防治。经济学评价能为提高卫生资源在大肠癌症防治领域的配置效率提供决策依据,本文对已发表大肠癌筛查经济学评价研究从发表时间、地域、评价方法、研究角度、投入产出测量、模型和策略推荐等多个角度进行了系统综述。

关键词: 大肠癌, 筛查, 经济学评价

Abstract: Colorectal cancer(CRC)has become one of the major cancer threatening residents′ health all around the world,and considerable resources are needed for its prevention and control.Economics evaluation could provide the basis of decision-making for improving the allocation efficiency of health resources in the field of CRC prevention and control.This paper comprehensively reviewed the papers that have been published in the field of colorectal cancer screening,from the points of view of published time,regional economic evaluation research,evaluation method,the research angle,input and output measurement,model,recommend strategy.

Key words: Colorectal cancer , Screening, Health economic evaluation

中图分类号:

R191

黄卫东, 于洪娟, 郑二维, 贺长志, 赵晓雯综述, 刘国祥校审. 大肠癌筛查经济学评价研究进展[J]. 实用肿瘤学杂志, 2015, 29(5): 462-466.

HUANG Weidong, YU Hongjuan, ZHENG Erwei, HE Changzhi, ZHAO Xiaowen, LIU Guoxiang. Progress on health economic evaluation of colorectal cancer screening[J]. PRACTICAL ONCOLOGY JOURNAL, 2015, 29(5): 462-466.

参考文献

1 Shimbo T,Glick HA,Eisenberg JM.Cost-effectiveness analysis of strategies for colorectal cancer screening in Japan[J].Int J Technol Assess Health Care,1994,10(3):359-375.
2 Whyte S,Chilcott J,Halloran S,Reappraisal of the options for colorectal cancer screening in England[J].Colorectal Dis,2012,14(9):547-561.
3 Wang ZH,Gao QY,Fang JY.Repeat colonoscopy every 10 years or single colonoscopy for colorectal neoplasm screening in average-risk Chinese:a cost-effectiveness analysis[J].Asian Pac J Cancer Prev,2012,13(5):1761-1766.
4 Sharp L,Tilson L,Whyte S,et al.Cost-effectiveness of population-based screening for colorectal cancer:a comparison of guaiac-based faecal occult blood testing,faecal immunochemical testing and flexible sigmoidoscopy[J].British Journal of Cancer,2012,106(5):805-816.
5 Lucidarme O,Cadi M,Berger G,et al.Cost-effectiveness modeling of colorectal cancer:computed tomography colonography vs colonoscopy or fecal occult blood tests[J].Eur J Radiol,2012,81(7):1413-1419.
6 Dan YY,Chuah BY,Koh DC,et al.Screening based on risk for colorectal cancer is the most cost-effective approach[J].Clin Gastroenterol Hepatol,2012,10(3):266-271.
7 Barouni M,Larizadeh MH,Sabermahani A,et al.Markov′s modeling for screening strategies for colorectal cancer[J].Asian Pacific Journal of Cancer Prevention,2012,13(10):5125-5129.
8 Vijan S,Hwang I,Inadomi J,et al.The cost-effectiveness of CT colonography in screening for colorectal neoplasia[J].American Journal of Gastroenterology,2007,102(2):380-390.
9 Paul T,James C,Simon E,et al.Option appraisal of population-based colorectal cancer screening programmes in England[J].Gut,2007,56(5):677-684.
10 Sieg A,Brenner H.Cost-saving analysis of screening colonoscopy in germany[J].Zeitschrift Für Gastroenterologie,2007,45(9):945-951.
11 Pickhardt PJ,Cesare H,Andrea L,et al.Cost-effectiveness of colorectal cancer screening with computed tomography colonography:the impact of not reporting diminutive lesions[J].Cancer,2007,109(11):2213-2221.
12 Hassan C,Zullo A,Laghi A,et al.Colon cancer prevention in Italy:Cost-effectiveness analysis with CT colonography and endoscopy[J].Dig Liver Dis,2007,39(3):242-250.
13 Chen LS,Liao CS,Chang SH,et al.Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening(KCIS 16)[J].J Med Screen,2007,14(4):191-199.
14 Lieberman D.Cost-effectiveness of screening colorectal cancer in the general population[J].Gastrointestinal Endoscopy,2001,54(4):537-538.
15 Khandker,RK,Dulski JD,Kilpatrick JB,et al.A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults[J].Int J Technol Assess Health Care,2000,16(3):799-810.
16 Loeve F,Brown ML,Boer R,et al.Endoscopic colorectal cancer screening:A cost-saving analysis[J].Journal of the National Cancer Institute,2000,92(7):557-563.
17 Ness RM,Holmes AM,Klein R,et al.Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages[J].American Journal of Gastroenterology,2000,95(7):1800-1811.
18 Sonnenberg A,Delcò F,Inadomi JM.Cost-effectiveness of colonoscopy in screening for colorectal cancer[J].Annals of Internal Medicine,2000,133(8):573-584.
19 Sonnenberg A,Delcò F,Bauerfeind P.Is virtual colonoscopy a cost-effective option to screen for colorectal cancer?[J].American Journal of Gastroenterology,1999,94(8):2268-2274.
20 Vijan S,Hwang EW,Hofer TP,et al.Which colon cancer screening test? A comparison of costs,effectiveness,and compliance[J].American Journal of Medicine,2001,111(8):593-601.
21 Parekh M,Fendrick A,Ladabaum U.As tests evolve and costs of cancer care rise:reappraising stool-based screening for colorectal neoplasia[J].Alimentary Pharmacology & Therapeutics,2008,27(8):697-712.
22 Hassan C,Zullo A,Winn S,et al.Cost-effectiveness of capsule endoscopy in screening for colorectal cancer[J].Endoscopy,2008,40(5):414-421.
23 Ho C,Heitman S,Membe SK,et al.Computed tomographic colonography for colorectal cancer screening in an average risk population:Systematic review and economic evaluation[D].Ottawa:Canadian Agency for Drugs and Technologies in Health;2008.
24 Telford JJ,Levy AR,Sambrook JC,et al.RESEARCH.The cost-effectiveness of screening for colorectal cancer[J].Cmaj Canadian Medical Association Journal,2010,182(12):1307-1313.
25 Heitman SJ,Hilsden RJ,Au F,et al.Colorectal Cancer Screening for Average-Risk North Americans:An Economic Evaluation[J].PLoS Medicine,2010,7(11):e1000370.
26 Berchi C,Bouvier V,Réaud JM,et al.Cost-effectiveness analysis of two strategies for mass screening for colorectal cancer in France[J].Health Economics,2004,13(3):227-238.
27 Lejeune C,Arveux P,Dancourt V,et al.Cost-effectiveness analysis of fecal occult blood screening for colorectal cancer[J].Int J Technol Assess Health Care,2004,20(4):434-439.
28 Lejeune C,Dancourt V,Arveux P,et al.Cost-effectiveness of screening for colorectal cancer in france using a guaiac test versus an immunochemical test[J].Int J Technol Assess Health Care,2010,26(1):40-47.
29 Heresbach D,Chauvin P,Grolier J,et al.Cost-effectiveness of colorectal cancer screening with computed tomography colonography or fecal blood tests[J].Eur J Gastroenterol Hepatol,2010,22(11):1372-1379.
30 Hassan C,Benamouzig R,Spada C,et al.Cost effectiveness and projected national impact of colorectal cancer screening in France[J].Endoscopy,2011,43(9):780-793.
31 Daniels K,McKee M.Options for screening for colorectal cancer in the Royal Air Force:a cost-effectiveness evaluation[J].Journal of the Royal Army Medical Corps,1995,141(3):142-150.
32 Whynes DK,Neilson AR,Walker AR,et al.Faecal occult blood screening for colorectal cancer:is it cost-effective?[J].Health Economics,1998,7(1):21-29.
33 Whynes DK,Nottingham FOB Screening Trial.Cost-effectiveness of screening for colorectal cancer:evidence from the Nottingham faecal occult blood trial[J].J Med Screen,2004,11(1):11-15.
34 Wilschut JA,Lieke H,Evelien D,et al.Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening[J].Gastroenterology,2011,141(5):1648-55.e1.
35 van Rossum LG,van RiJn AF,Verbeek AL,et al.Colorectal cancer screening comparing no screening,immunochemical and guaiac fecal occult blood tests:a cost-effectiveness analysis[J].Int J Cancer,2011,128(8):1908-1917.
36 Sorrentino D,Paduano R,Bernardis V,et al.Colorectal cancer screening in Italy:feasibility and cost-effectiveness in a model area[J].Eur J Gastroenterol Hepatol,1999,11(6):655-660.
37 Norum J.Prevention of colorectal cancer:A cost-effectiveness approach to a screening model employing sigmoidoscopy[J].Annals of Oncology,1998,9(6):34-35.
38 Wu GH,Wang YM,Yen AM,et al.Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries[J].BMC Cancer,2006,6(16):136-148.
39 Wong SS,Leong AP,Leong TY.Cost-effectiveness analysis of colorectal cancer screening strategies in Singapore:a dynamic decision analytic approach[J].Stud Health Technol Inform,2004,107(1):104-110.
40 Leshno M,Halpern Z,Arber N.Cost-effectiveness of colorectal cancer screening in the average risk population[J].Health Care Management Science,2003,6(3):165-174.
41 Tsoi KKF,Ng SSM,Leung MCM,et al.Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia[J].Alimentary Pharmacology & Therapeutics,2008,28(3):353-363.
42 Salkeld G,Young G,Irwig L.Cost-effectiveness analysis of screening by faecal occult blood testing for colorectal cancer in Australia[J].Aust N Z J Public Health,1996,20(2):138-143.

[1]	张夏兰, 沈夕坤, 黄玉宇. 营养风险筛查2002在晚期肿瘤患者营养状况筛查中的运用[J]. 实用肿瘤学杂志, 2018, 32(3): 229-233.
[2]	吕强, 陈洪生, 李国东, 魏九峰(综述), 刘明(审校). 肿瘤相关成纤维细胞在大肠癌发生发展中的研究进展[J]. 实用肿瘤学杂志, 2018, 32(3): 275-279.
[3]	孔维嘉, 安甜, 吕博, 姜广建. 低剂量螺旋CT肺癌筛查及肺结节的研究现状[J]. 实用肿瘤学杂志, 2018, 32(1): 68-72.
[4]	顾秀瑛，顾晓芬，朱俊宇，周天虹，朱琳. 2014-2016年乌鲁木齐市9265例城市居民肺癌筛查结果分析[J]. 实用肿瘤学杂志, 2017, 31(3): 242-245.
[5]	曲亚兰, 谢宝芳, 李丹阳. 流式细胞术联合阴道镜活检在宫颈癌和癌前病变筛查中的意义[J]. 实用肿瘤学杂志, 2017, 31(1): 31-34.
[6]	段佩雯, 赵苗苗综述, 王松坡审校. NF-κB对大肠癌发生发展的影响及其相关治疗的研究现状[J]. 实用肿瘤学杂志, 2017, 31(1): 43-47.
[7]	吴杨佳子,鹿晓麟,赵琦,高玉艳,张艳桥. Arg-1在大肠炎症相关性肿瘤中的表达及意义[J]. 实用肿瘤学杂志, 2016, 30(4): 339-345.
[8]	王倩, 陈铁龙, 王彩芹, 罗微. 大肠癌中CD133、COX-2的表达及DNA倍体的研究[J]. 实用肿瘤学杂志, 2016, 30(3): 200-206.
[9]	廖先珍, 颜仕鹏, 石菊芳, 石朝晖, 邹艳花, 肖海帆, 许可葵, 朱松林. 城市女性乳腺癌高危评估及筛查结果分析[J]. 实用肿瘤学杂志, 2016, 30(3): 245-248.
[10]	张津宁, 李国东, 陈洪生综述, 刘明校审. 鞣花酸及其肠道代谢产物在大肠癌中的研究进展[J]. 实用肿瘤学杂志, 2016, 30(3): 262-265.
[11]	钟选芳, 肖丹, 李琛, 许岸高, 张晓慧, 甘爱华. 大肠肿瘤患者粪便和组织中APC、p53和K-ras基因突变的研究[J]. 实用肿瘤学杂志, 2016, 30(2): 118-122.
[12]	宫晨,周军德,迟强,崔滨滨,赵亚双,王帆. CYP24A1基因多态性与大肠癌发生及预后的关系[J]. 实用肿瘤学杂志, 2015, 29(4): 289-293.
[13]	孙惠昕,陈王洋,宋冰冰. 黑龙江省2013—2014年度城市癌症筛查分析[J]. 实用肿瘤学杂志, 2015, 29(4): 315-318.
[14]	方东, 王志红. 中性粒细胞/淋巴细胞比值在大肠癌癌变进展中的指示价值[J]. 实用肿瘤学杂志, 2015, 29(1): 44-48.
[15]	崔滨滨, 刘彦龙, 陈洪生, 周飞, 于雪峰, 徐海涛. 抑癌基因ING3在大肠癌中表达及意义[J]. 实用肿瘤学杂志, 2014, 28(6): 481-484.